USPTO 2015–2025 USPTO PatentsView US Corporation

Bioatla, Inc.

USPTO PatentsView assignee record - 43 granted patents across 12 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07K (PEPTIDES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

20.3

Avg claims per patent

+158%

5-year filing velocity

The verdict

Bioatla holds 43 US patents across 12 technology areas, rank #7,532 of 50,000 tracked assignees.

#7,532
of 50,000 US assignees by volume: Top 17%
by Innovation Score (48.1/100): 20.3
avg claims per patent: +158%
filing velocity, last 5 yrs

Portfolio overview

Bioatla, Inc. has been granted 43 US utility patents between 2016 and 2025, placing Bioatla, Inc. at rank #7,532 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.3 claims per patent with primary concentration in C07K (PEPTIDES). As a US Corporation, Bioatla, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Bioatla sits between Bongiovi Acoustic Llc (43 patents, rank #7,528) and CALB Co., Ltd. (43 patents, rank #7,536) - the closest US assignees by grant volume. The composite Innovation Score of 48.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 31 grants, compared with 12 in the 2015–2019 window, a +158% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Bioatla, Inc.'s 20.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bioatla, Inc. against peers pursuing similar technology classes.

Bongiovi Acoustic

43
Boston Medical Ce…

43
Balenciaga

43
Bank of Montreal

43
Bracco Suisse

43
Bruin Biometrics

43
Buster and Punch

43
CALB

43
Bioatla ◀

43

What this shows Bioatla holds 43 patents at rank #7,532, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bioatla

By rank, the assignees closest to #7,532 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Bioatla's primary technology class.

Bioatla's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Bioatla, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.3%
2017	2	4.7%
2018	7	16.3%
2019	2	4.7%
2020	6	14.0%
2021	4	9.3%
2022	7	16.3%
2023	7	16.3%
2024	5	11.6%
2025	2	4.7%

Which technologies does Bioatla, Inc. patent most?

C07K - PEPTIDES 41

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 27

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 26

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 24

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 22

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 13

C12Y - ENZYMES 6

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 6

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 3

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 3

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 1

Top 12 of 12 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#7,532

Across all tracked assignees

Innovation Score

48.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Bioatla, Inc. hold?

Bioatla, Inc. holds 43 US granted patents filed between 2016 and 2025, spanning 12 technology areas.

What is Bioatla, Inc.'s Innovation Score?

Bioatla, Inc. has an Innovation Score of 48.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bioatla, Inc. focus on?

Bioatla, Inc.'s top technology area is C07K (PEPTIDES) with 41 patents. The company has filed patents in 12 CPC subclasses total.

Is Bioatla, Inc.'s patent filing rate increasing or decreasing?

Bioatla, Inc.'s recent filing velocity is +158% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Bioatla, Inc.'s patents?

Bioatla, Inc.'s patents average 20.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Bioatla, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Bioatla's 43 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Bioatla ranks #7,532 of 50,000. Top 50 holders
Most of this portfolio concentrates in C07K - see who else leads that technology area. C07K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.